Group B Streptococcus (GBS) is the most common life threatening infection in newborns and a leading cause of newborn death in the United States. Group B Strep infects about 3,200 newborns every year in the United States.
One in 20 babies infected with GBS dies from the infection or complications. Surviving babies may endure significant illnesses such as pneumonia, meningitis, sepsis, and long-term medical problems such as hearing or vision loss, learning disabilities, or neurological difficulties.
About 25% of women carry the Group B Strep bacteria, but it is usually not dangerous to women. It can cause bladder and womb infections, but often goes undetected. However in newborns it can result in lifelong damage or even death.
In the fall of 2002, the Centers for Disease Control (CDC) recommended changes in the method of screening of expectant mothers. The CDC's revised guidelines recommend universal prenatal screening for Group B Strep of all pregnant women at 35-37 weeks' gestation. The CDC recommends that women whose culture results are unknown at the time of delivery should be managed according to the clinical risk-based approach.
Dr. Craig Rubens' research at Children's has focused on how Group B Strep bacteria causes infections in newborns and pregnant women. Dr. Rubens has begun to identify the important factors produced by this bacteria, some of which have been targeted for a vaccine or new antibiotic therapies.
Key Facts About Group B Strep Prevention:
For GBS advocacy questions, contact Dr. Craig Rubens.